PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Symptom | C0001418|adenocarcinoma |
| Sentences | 59 |
| PubMedID- 25035393 | Fgfr2 and other fgfr kinase family gene alterations have been found in both lung squamous cell carcinoma and lung adenocarcinoma, although mouse models of fgfr-driven lung cancers have not been reported. |
| PubMedID- 21224613 | The histopathological examination demonstrated papillary adenocarcinoma similar to that of the lung cancer with lymph node metastasis. |
| PubMedID- 22566257 | A case of resected synchronous multiple primary lung cancer comprising adenocarcinoma and carcinoid (cancer-in-cancer). |
| PubMedID- 22969248 | When compared with patients in the old age group, females, non-smokers, and those with a more advanced stage at diagnosis and histologic type of adenocarcinoma were predominant in patients with lung cancer in the young age group. |
| PubMedID- 23617234 | In this report, we described a case of synchronous bilateral lung cancers with eml4-alk positive adenocarcinoma in the right lung and adenocarcinoma in situ in the left, which was eml4-alk negative. |
| PubMedID- 25859693 | Blood samples (plasma) in study 1 (fhcrc study) were taken from newly diagnosed lung cancer patients with nsclc adenocarcinoma (mostly late stage) and were frequency matched with for age, gender and for general smoking history (current and former smokers) (table 1a). |
| PubMedID- 26161361 | The loss of blood group antigen a expression has a negative prognostic impact in stage i non-small cell lung cancer, especially in patients with adenocarcinoma (265). |
| PubMedID- 22719810 | In the present study, we report on a case of a remarkable effect of gefitinib re-treatment in a lung cancer patient with lepidic predominant adenocarcinoma who had experienced favorable results from initial treatment with gefitinib. |
| PubMedID- 26491504 | The most common histological type of lung cancer among patients with ssc is adenocarcinoma 2. |
| PubMedID- 24113011 | Compared with lung adenocarcinoma, treatment of squamous cell lung cancer (scc) has been far behind. |
| PubMedID- 24932291 | Lung adenocarcinoma accounts for ~70% of non-small cell lung cancer and is now becoming more frequently detected (2). |
| PubMedID- 23951859 | Currently, adenocarcinoma represents 41 % of primary lung cancers in women and 34 % in men. |
| PubMedID- 23154768 | Epidermal growth factor receptor (egfr) gene mutation and high gene copy number (cn) predict response to egfr tyrosine kinase inhibitor therapy in the adenocarcinoma subtype of non-small cell lung cancer (nsclc). |
| PubMedID- 22429580 | We identified the dynamic changes of the immune system by investigating the levels of t lymphocyte subsets in peripheral blood of lung cancer patients with advanced stage adenocarcinoma undergoing first line chemotherapy. |
| PubMedID- 25884512 | An example is represented by the adenocarcinoma subgroup of non-small-cell lung cancer (nsclc), in which using high throughput technology it has been possible to identify driver genetic alterations in approximately 75% of the cases 2. |
| PubMedID- 23443124 | Study subjects included 99 lung cancer patients (65 with lung adenocarcinoma, 29 with lung squamous cell carcinoma, and 5 with other carcinomas) who were after surgical treatment but not receiving radiotherapy and chemotherapy and were included in previous studies that investigated the genetic polymorphisms of dna repair proteins and metabolic enzymes . |
| PubMedID- 24649233 | adenocarcinoma accounts for ∼50% of lung cancer cases in senile patients. |
| PubMedID- 26022944 | Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma. |
| PubMedID- 24913807 | The driver mutational patterns in pulmonary mucinous adenocarcinoma, a rare subtype of non-small-cell lung cancer, have not been well studied. |
| PubMedID- 23961259 | Background: adenocarcinoma, a subgroup of non-small cell lung cancer, is the most frequent form occurring in the non-smokers. |
| PubMedID- 24137392 | Egfr mutations, which are mostly limited to the first four exons, occur more often in lung cancer patients with adenocarcinoma histology, asian origin, female gender and a non-smoking background (13,15). |
| PubMedID- 22588153 | Four genes (tenascin-c, c-x-c motif ligand 14, s100 calcium binding protein a9, and keratin 17) were found to be upregulated in elf of non-small-cell lung cancer patients with adenocarcinoma or squamous cell carcinoma. |
| PubMedID- 23154565 | First case of combined small-cell lung cancer with adenocarcinoma harboring eml4-alk fusion and an exon 19 egfr mutation in each histological component. |
| PubMedID- 24811831 | Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma. |
| PubMedID- 24932312 | The present study investigated whether plasma mtdna concentrations in lung cancer patients with adenocarcinoma were altered during treatment with erlotinib, an epidermal growth factor receptor-tyrosine kinase inhibitor (egfr-tki), and whether this change has the potential to be used as a predictor of treatment response. |
| PubMedID- 23529818 | Purpose: to discover common metastasis-related and prognostic markers in lung squamous carcinoma (lsc) and lung adenocarcinoma (adc), two forms of non-small cell lung cancer (nsclc). |
| PubMedID- 22384154 | Enzyme-linked immunosorbent assay (elisa) measurements of h. pylori seropositivity were available from 98 lung cancer cases (11 with documented adenocarcinoma and 33 with squamous cell carcinoma) and over 1500 subjects without lung cancer. |
| PubMedID- 22024018 | The distributions of selected characteristics among study subjects are summarized in table 1. our analysis included 462 lung cancer patients (242 with adenocarcinoma, 131 with squamous cell carcinoma, 69 with small cell carcinoma, and 20 with large cell carcinoma). |
| PubMedID- 20967496 | 7australian and us adenocarcinoma as a proportion of designated lung cancers. |
| PubMedID- 25766505 | Background: the adenocarcinoma subtype of non-small cell lung cancer (adeno-nsclc) is routinely treated with chemotherapy if patients do not have molecular aberrations such as epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements. |
| PubMedID- 23494387 | lung cancer patients with adenocarcinoma histology may benefit most from treg-targeted therapy. |
| PubMedID- 23181744 | In the past decades, lung adenocarcinoma, one histological subtype of non-small cell lung cancer (nsclc), has become the most common histologic type among all lung cancers diagnosed2. |
| PubMedID- 21352550 | The percent of lung cancer patients with adenocarcinoma was lower in current and former smokers than in never-smokers (64.3% versus 79.9%, p = 0.0004), while the percent with squamous cell carcinoma was higher in smokers than in never-smokers (15.5% versus 8.3%, p = 0.028). |
| PubMedID- 23409158 | Among lung cancer patients, those with adenocarcinoma, squamous cell cancer, small cell cancer, and unspecified lung cancer accounted for 37.54%, 32.26%, 20.83%, and 9.38%, respectively. |
| PubMedID- 24678343 | There was no trend with a dose above 75 mg per day, and the effect was particularly evident in adenocarcinoma, the leading type of lung cancer today. |
| PubMedID- 24008636 | These tumors were pathologically diagnosed as synchronous multiple primary lung cancers with adenocarcinoma and squamous cell carcinoma. |
| PubMedID- 26010604 | Nsclc comprises 85% of all lung cancer cases, with adenocarcinoma (ac) representing the major histological subtype of nsclc 1. |
| PubMedID- 25657018 | adenocarcinoma, a type of non-small cell lung cancer, is the most frequently diagnosed lung cancer and the leading cause of lung cancer mortality in the united states. |
| PubMedID- 24564548 | It can be classified into two main types: small-cell lung carcinoma (sclc) and non-small-cell lung carcinoma (nsclc) and nsclc includes three main subtypes: adenocarcinoma (adc, about 40% of lung cancers), squamous-cell lung carcinoma (scc, about 30% of lung cancers), and large-cell lung carcinoma (about 9% of lung cancers). |
| PubMedID- 21731750 | This study focuses on lung adenocarcinoma, a histological subtype of lung cancer that is increasing in many countries –, and which currently accounts for at least 37% of all lung cancer in the united states 4. |
| PubMedID- 22253823 | Nsclc accounts for about 80% of all lung cancer cases, with adenocarcinoma predominating. |
| PubMedID- 20217555 | To identify and characterize novel lung adenocarcinoma genes associated with lung cancer progression, we created a bioinformatics-based approach that focuses on human cell-cycle-regulated genes that have evolved only in higher organisms but not in lower eukaryotic cells. |
| PubMedID- 22729036 | High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and egfr corrected mutation. |
| PubMedID- 23180523 | lung cancer, including adenocarcinoma, was the most common type of malignancy, present in 44 (67%) patients. |
| PubMedID- 24325900 | Magnetic resonance imaging (mri) in january 2012 confirmed a right renal mass, and subsequent biopsy showed adenocarcinoma consistent with metastatic lung cancer (ttf1+, napsin-a+, pax-8–). |
| PubMedID- 21847065 | Alk translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers. |
| PubMedID- 21411176 | Serum samples from 29 healthy volunteers and 33 lung cancer patients with adenocarcinoma (n=12), squamous cell carcinoma (n=11), or small cell carcinoma (n=10) ranging from stage i to stage iv disease and lung tissue samples from 7 lung cancer patients including the tumor tissue and its surrounding normal tissue were used. |
| PubMedID- 24932292 | In previous studies, adenocarcinoma accounted for 11–53% of patients with lung cancer and hpo (table ii), whereas squamous cell carcinoma accounted for ~25–50%. |
| PubMedID- 25963978 | In the past decade, lung adenocarcinoma, a subtype of non-small cell lung cancer (nsclc), has become the most common histological type among all lung cancers diagnosed. |
| PubMedID- 24885564 | Background: although many of the recently approved genomically targeted therapies have improved outcomes for patients in non-small-cell lung cancer (nsclc) with lung adenocarcinoma, little is known about the genomic alterations that drive lung squamous cell cancer (scc) and development of effective targeted therapies in lung scc is a promising area to be further investigated. |
Page: 1 2